Prince Pharmaceutical Co., Ltd. (TPEX:6935)
Taiwan · Delayed Price · Currency is TWD 27.20
-1.30 (-4.56%)
Sep 30, 2026, 1:29 PM CST
Prince Pharmaceutical Market Cap
Prince Pharmaceutical has a market cap or net worth of 1.07 billion as of September 29, 2026. Its market cap has decreased by -17.02% in one year.
Market Cap
1.07B
Enterprise Value
1.25B
Revenue
1.22B
Ranking
n/a
PE Ratio
8.18
Stock Price
27.20
ChartMarket Cap Chart
Since March 29, 2023, Prince Pharmaceutical's market cap has decreased from 1.94B to 1.07B, a decrease of -45.14%. That is a compound annual growth rate of -15.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 29, 2026 | 1.07B | -6.34% |
| Dec 31, 2025 | 1.14B | 42.01% |
| Dec 31, 2024 | 801.65M | -36.72% |
| Dec 29, 2023 | 1.27B | -34.82% |
| Mar 29, 2023 | 1.94B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TSH Biopharm Corporation | 1.93B |
| InnoPharmax | 1.28B |
| GeneFerm Biotechnology | 1.22B |
| Excelsior Biopharma | 1.09B |
| Anxo Pharmaceutical | 1.07B |
| DV Biomed | 989.79M |
| Original BioMedicals | 851.80M |
| Winston Medical Supply | 823.24M |